Correction to: Efficacy and safety of avacopan in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: A subanalysis of a randomized Phase 3 study
- PMID: 38801299
- DOI: 10.1093/mr/roae045
Correction to: Efficacy and safety of avacopan in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: A subanalysis of a randomized Phase 3 study
Erratum for
-
Efficacy and safety of avacopan in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: A subanalysis of a randomized Phase 3 study.Mod Rheumatol. 2023 Mar 2;33(2):338-345. doi: 10.1093/mr/roac037. Mod Rheumatol. 2023. PMID: 35482532 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
